Phase I/II Study of Vinorelbine and Exisulind as First-Line Treatment of Advanced Non-small Cell Lung Cancer in Patients at Least 70 Years Old: A Wisconsin Oncology Network Study

This combination is safe, seems to have activity in the elderly with advanced NSCLC and a PS ≤2, and warrants further investigation.